COMMUNIQUÉS West-GlobeNewswire

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
11/03/2026
Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments, runway through 2027 Completed $ [...]
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process
11/03/2026
– Base biologic matrix NXT-41 submitted to FDA; on track for anticipated FDA clearance in second half of 2026 and full NXT-41x clearance in 1H27 – – $44.4 million in cash and escrowed proceeds at year-end – – Conference [...]
Rad Source Technologies Announces Configurable Filters for the RS® 2000·Q2 Biological Irradiator
11/03/2026
BUFORD, Ga., March 11, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies (Rad Source ® ), a global leader in advanced X‑ray solutions for life sciences, today announced the launch of Configurable Filters for the RS ® [...]
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
11/03/2026
WARREN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today issued a statement from Founder and CEO Dr. Ryan Saadi regarding the company’s progress in [...]
Human Appeal's #ForMama26 Campaign to Save only Maternity Hospital in Northwest Syria
11/03/2026
Partnership with Every Pregnancy aims to provide a critical lifeline for thousands of mothers and babies at Al Imaan Hospital through a matched funding campaign MISSION VIEJO, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
11/03/2026
Please see enclosed pdf. Attachment 11032026_trading_in_shares_JNA
BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
11/03/2026
- Phase 3 FORTIFY interim analysis results presented in a late-breaking oral presentation at MDA highlight the broad and consistent efficacy of BBP-418 across key clinical endpoints and prespecified subgroups - Early [...]
Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
11/03/2026
CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the purchase of $600,000 of [...]
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
11/03/2026
- 40 participants have been dosed with SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration [...]
GUERBET : Evolution du Conseil d’Administration de Guerbet.
11/03/2026
Evolution du Conseil d’Administration de Guerbet Villepinte, le 11 mars 2026 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination ce [...]
GUERBET : Change in Guerbet’s Board of Directors.
11/03/2026
Change in Guerbet’s Board of Directors Villepinte, March 11th, 2026: Guerbet (FR0000032526 GBT), a global leader in contrast agents and solutions for medical imaging, today announced, at its Board of Directors’ meeting [...]
GUERBET : Résultats annuels 2025.
11/03/2026
Résultats annuels 2025 Chiffre d’affaires : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , dû essentiellement à la baisse de l’activité en France Rentabilité : la marge d’EBITDA retraité 3 ressort à [...]
GUERBET : 2025 full-year results.
11/03/2026
2025 full-year results Revenue : €786.4 million, down 3.5% at CER 1 and like-for-like 2 , mainly due to the fall in activity in France Profitability : restated EBITDA margin 3 of 12.0% (at the high end of the adjusted [...]
Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
11/03/2026
SPRING, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of Texas MD Anderson [...]
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite
11/03/2026
March 11, 2026 Fully cloud ‑ enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader [...]
Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter
11/03/2026
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Toro Neurovascular today announced that the U.S. Food and Drug [...]
Nelipak Announces Opening of Asia-Pacific Technical Development Center
11/03/2026
New Singapore facility integrates flexible and rigid sterile barrier packaging systems development under one roof to simplify and accelerate package design and speed to market (L-R) Roger Prevot, Chairman, Nelipak, [...]
PolTREG poursuit la procédure d’enregistrement au niveau européen de sa thérapie à base de TREG destinée au traitement du diabète de type 1
11/03/2026
L’Agence européenne des médicaments (EMA) a officiellement autorisé PolTREG à déposer une demande d’autorisation de mise sur le marché dans l’Union européenne pour la préparation cellulaire PolTREG-T1D. GDAŃSK, Pologne [...]
Inc. Names Commure’s Deepika Bodapati to Its 2026 Female Founders 500 List
11/03/2026
Inc.’s annual Female Founders list celebrates the nation’s most innovative women entrepreneurs, who collectively generated approximately $12.3 billion in 2025 MOUNTAIN VIEW, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- [...]

Pages